Bacterial antibiotic resistance development and mutagenesis following exposure to subinhibitory concentrations of fluoroquinolones in vitro: a systematic review of the literature
| Autor: | Veronika J. Wirtz, Muhammad H. Zaman, Ebiowei Samuel F Orubu, Indorica Sutradhar, Carly Ching, Helen W. Boucher |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Drug Bacterial antibiotic resistance medicine.drug_class business.industry media_common.quotation_subject 030106 microbiology Antibiotics Mutagenesis (molecular biology technique) Bioinformatics In vitro 03 medical and health sciences 030104 developmental biology Antibiotic resistance AcademicSubjects/MED00290 medicine AcademicSubjects/MED00740 Efflux Systematic Review business AcademicSubjects/MED00230 media_common Specific resistance |
| Zdroj: | JAC-Antimicrobial Resistance |
| ISSN: | 2632-1823 |
| Popis: | Background Understanding social and scientific drivers of antibiotic resistance is critical to help preserve antibiotic efficacy. These drivers include exposure to subinhibitory antibiotic concentrations in the environment and clinic. Objectives To summarize and quantify the relationship between subinhibitory fluoroquinolone exposure and antibiotic resistance and mutagenesis to better understand resistance patterns and mechanisms. Methods Following PRISMA guidelines, PubMed, Web of Science and Embase were searched for primary in vitro experimental studies on subinhibitory fluoroquinolone exposure and bacterial antibiotic resistance and mutagenesis, from earliest available dates through to 2018 without language limitation. A specifically developed non-weighted tool was used to assess risk of bias. Results Evidence from 62 eligible studies showed that subinhibitory fluoroquinolone exposure results in increased resistance to the selecting fluoroquinolone. Most increases in MIC were low (median minimum of 3.7-fold and median maximum of 32-fold) and may not be considered clinically relevant. Mechanistically, resistance is partly explained by target mutations but also changes in drug efflux. Collaterally, resistance to other fluoroquinolones and unrelated antibiotic classes also develops. The mean ± SD quality score for all studies was 2.6 ± 1.8 with a range of 0 (highest score) to 7 (lowest score). Conclusions Low and moderate levels of resistance and efflux changes can create an opportunity for higher-level resistance or MDR. Future studies, to elucidate the genetic regulation of specific resistance mechanisms, and increased policies, including surveillance of low-level resistance changes or genomic surveillance of efflux pump genes and regulators, could serve as a predictor of MDR development. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|